
Opinion|Videos|January 27, 2025
Supporting Mothers With Postpartum Depression and Promoting Culturally Sensitive Care
Panelists discuss how faster-acting treatments like zuranolone might improve patient outcomes and quality of life, the initial signs to monitor for assessing effectiveness, barriers to accessing such therapies in underserved populations and strategies to increase accessibility, approaches to ensuring safety while addressing distress in patients with intrusive thoughts, effective strategies for managing sleep issues in postpartum depression (PPD), advice for the psychiatry community when treating PPD, and how to tailor advice for clinicians working with underserved populations.
Advertisement
Episodes in this series

Advertisement
Latest CME
Advertisement
Advertisement
Trending on Psychiatric Times
1
Repurposing Dopamine Agonist Pramipexole for Disabling Anhedonia
2
When Treatment-Resistant Depression Means Mismatched: Rethinking Difficult-to-Treat Depression
3
Brain Trust: Anita H. Clayton, MD, on Diagnosing and Treating Sexual Dysfunction
4
The Year So Far in GLP-1s: What Psychiatric Clinicians Need to Know
5











